company background image
506943 logo

J. B. Chemicals & Pharmaceuticals BSE:506943 Stock Report

Last Price


Market Cap







29 May, 2024


Company Financials +

J. B. Chemicals & Pharmaceuticals Limited

BSE:506943 Stock Report

Market Cap: ₹274.5b

506943 Stock Overview

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

506943 fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance5/6
Financial Health5/6

J. B. Chemicals & Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for J. B. Chemicals & Pharmaceuticals
Historical stock prices
Current Share Price₹1,768.65
52 Week High₹1,935.00
52 Week Low₹1,037.33
1 Month Change-7.22%
3 Month Change13.62%
1 Year Change68.31%
3 Year Change134.11%
5 Year Change826.84%
Change since IPO69,395.12%

Recent News & Updates

Recent updates

Shareholder Returns

506943IN PharmaceuticalsIN Market

Return vs Industry: 506943 exceeded the Indian Pharmaceuticals industry which returned 58.3% over the past year.

Return vs Market: 506943 exceeded the Indian Market which returned 43.4% over the past year.

Price Volatility

Is 506943's price volatile compared to industry and market?
506943 volatility
506943 Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 506943 has not had significant price volatility in the past 3 months.

Volatility Over Time: 506943's weekly volatility (4%) has been stable over the past year.

About the Company


J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.

J. B. Chemicals & Pharmaceuticals Limited Fundamentals Summary

How do J. B. Chemicals & Pharmaceuticals's earnings and revenue compare to its market cap?
506943 fundamental statistics
Market cap₹274.50b
Earnings (TTM)₹5.53b
Revenue (TTM)₹35.21b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506943 income statement (TTM)
Cost of Revenue₹11.82b
Gross Profit₹23.39b
Other Expenses₹17.87b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)35.61
Gross Margin66.43%
Net Profit Margin15.69%
Debt/Equity Ratio12.2%

How did 506943 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.